Cytek Biosciences (CTKB) Other Accumulated Expenses (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Other Accumulated Expenses came in at $22.2 million in Q1 2026, up 72.74% YoY from $12.8 million in Q1 2025, and up 30.6% on a QoQ basis from $17.0 million in Q4 2025.
Cytek Biosciences (CTKB) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Other Accumulated Expenses data on file, last reported at $22.2 million in Q1 2026.
- Quarterly Other Accumulated Expenses rose 72.74% year-over-year to $22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.2 million (up 72.74% YoY) and the FY2025 annual result came in at $17.0 million, up 25.82% from the prior year.
- Other Accumulated Expenses improved to $22.2 million in Q1 2026, from $17.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $22.2 million in Q1 2026 to a low of $4.9 million in Q3 2022.
- A 5-year average of $10.8 million and a median of $8.4 million in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 316.73% — and 2024, when it dropped 24.24%.
- Tracing CTKB's Other Accumulated Expenses over 5 years: stood at $8.0 million in 2022, then declined by 0.72% to $7.9 million in 2023, then surged by 70.75% to $13.5 million in 2024, then rose by 25.82% to $17.0 million in 2025, then surged by 30.6% to $22.2 million in 2026.
- The last three Other Accumulated Expenses figures came in at $22.2 million (Q1 2026), $17.0 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.51 Mn |
| Mar 31, 2026 | 22.17 Mn |
| Dec 31, 2025 | 16.98 Mn |
| Sep 30, 2025 | 16.43 Mn |
| Jun 30, 2025 | 14.72 Mn |
| Mar 31, 2025 | 12.84 Mn |
| Dec 31, 2024 | 13.49 Mn |
| Sep 30, 2024 | 8.81 Mn |
| Jun 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 7.90 Mn |
| Sep 30, 2023 | 7.82 Mn |
| Jun 30, 2023 | 8.39 Mn |
| Mar 31, 2023 | 10.86 Mn |
| Dec 31, 2022 | 7.96 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 5.63 Mn |
| Mar 31, 2022 | 8.39 Mn |
| Dec 31, 2021 | 6.35 Mn |
| Sep 30, 2021 | 2.04 Mn |